Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers?
Authors:
- Anna JakubowskaAJAnna Jakubowska
- Katarzyna JaworskaKJKatarzyna Jaworska
- Cezary CybulskiCCCezary Cybulski
- Anna JanickaAJAnna Janicka
- Jolanta Szymańska-PasternakJSJolanta Szymańska-Pasternak
- Marcin LenerMLMarcin Lener
- Steven A. NarodSNSteven A. Narod
- Jan LubińskiJLJan Lubiński
- 1 March 2009
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 45 (5) , 837-842
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphismBMC Cancer, 2008
- The VEGF_936_C>T 3′UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish womenCancer Letters, 2008
- Integrin 3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer riskJournal of Medical Genetics, 2007
- The RAD51 135 G>C Polymorphism Modifies Breast Cancer and Ovarian Cancer Risk in Polish BRCA1 Mutation CarriersCancer Epidemiology, Biomarkers & Prevention, 2007
- Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risksBreast Cancer Research and Treatment, 2006
- The 3′ untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutationBreast Cancer Research and Treatment, 2006
- Breast cancer predisposing alleles in PolandBreast Cancer Research and Treatment, 2005
- A high proportion of founder BRCA1 mutations in Polish breast cancer familiesInternational Journal of Cancer, 2004
- Single nucleotide polymorphism in prohibitin 3′untranslated region and breast-cancer susceptibilityThe Lancet, 2001
- Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian CancerThe American Journal of Human Genetics, 2000